Novavax is $1.6 billion richer
Novavax, which has burned through $1.5 billion in its 32 years of existence, is about to make all of that back from the U.S. government, in exchange for 100 million doses of a coronavirus vaccine that may or may not work.
As STAT’s Helen Branswell reports, Novavax is the latest inductee into Operation Warp Speed, the Trump administration’s program to speed up the development of vaccines to prevent Covid-19. The $1.6 billion, which Novavax expects to receive in February, comes on top of $388 million the company received from the Coalition for Epidemic Preparedness Innovations, or CEPI.
As to whether Novavax’s vaccine works, the company expects to have data from a Phase 1 trial later this month. If everything pans out, Novavax said it will start a 30,000-volunteer Phase 3 trial in the third quarter.
Read more.
As STAT’s Helen Branswell reports, Novavax is the latest inductee into Operation Warp Speed, the Trump administration’s program to speed up the development of vaccines to prevent Covid-19. The $1.6 billion, which Novavax expects to receive in February, comes on top of $388 million the company received from the Coalition for Epidemic Preparedness Innovations, or CEPI.
As to whether Novavax’s vaccine works, the company expects to have data from a Phase 1 trial later this month. If everything pans out, Novavax said it will start a 30,000-volunteer Phase 3 trial in the third quarter.
Read more.
No hay comentarios:
Publicar un comentario